pfizer expects 2022 sales its covid-19 vaccine antiviral pill top $54 billion. final sales its oral covid-19 antiviral, paxlovid, could be "way bigger" than what pfizer forecast. pfizer currently expects $22 billion 2022 sales treatment. #pfizer #covid19